Search

BSI President Professor Arne Akbar who is finishing his term in December 2022 reflects on his time as President and the challenges immunology still faces.

Dr Doug Brown will be leaving his role as the BSI’s Chief Executive at the end of August to take up the position of Chief Executive at the Royal Society of Biology. In his seven years with the BSI, Doug has led a huge transformation in terms of how we operate, including implementation of a new strategy and business model to secure the Society’s financial sustainability. We caught up with Doug to hear his reflections on his time at the BSI, and his hopes for the future.

In November, we welcomed Graham Blair to the BSI as our new Chief Executive. We caught up with Graham to hear a bit more about his background and motivations for joining the BSI, and to find out what he’s looking forward to most about his new role.

We were delighted to welcome Professor Mauri to the team of our longest standing journal Clinical & Experimental Immunology (CEI) as Editor-in-Chief in January. Here, we caught up with Professor Mauri to find out more about her fascinating career, and about her vision for the journal.

We are now approaching a year since the launch of the BSI-CIPN Strategic Plan 2024–2027, and time has flown! The first year of implementation of the strategy has involved a lot of collaboration and hard work, and a chance to convene in person in Birmingham at the BSI-CIPN Conference 2024.

Clinical guidelines are key to standardising and improving quality, supporting the translation of research into clinical practice, and ensuring clinicians have access to the latest consensus on diagnostics, treatment and care. This article explores the ongoing and upcoming work of the BSI-CIPN Clinical Guidelines Special Interest Group.